TR2021016542A2 - Plazma bazlı filmler ve bunları üretme ve kullanma usulleri. - Google Patents

Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.

Info

Publication number
TR2021016542A2
TR2021016542A2 TR2021/016542A TR2021016542A TR2021016542A2 TR 2021016542 A2 TR2021016542 A2 TR 2021016542A2 TR 2021/016542 A TR2021/016542 A TR 2021/016542A TR 2021016542 A TR2021016542 A TR 2021016542A TR 2021016542 A2 TR2021016542 A2 TR 2021016542A2
Authority
TR
Turkey
Prior art keywords
plasma
based films
methods
making
same
Prior art date
Application number
TR2021/016542A
Other languages
English (en)
Inventor
Grant Ericson Daniel
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of TR2021016542A2 publication Critical patent/TR2021016542A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Abstract

Bu buluş plazma bazlı filmlere ve özellikle esnek, plazma bazlı filmlere ilişkindir. Buluş ayrıca esnek, plazma bazlı filmler üretme ve kullanma usullerine ilişkindir.
TR2021/016542A 2016-05-31 2017-05-31 Plazma bazlı filmler ve bunları üretme ve kullanma usulleri. TR2021016542A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662343840P 2016-05-31 2016-05-31
EP17734180.7A EP3463498B1 (en) 2016-05-31 2017-05-31 Plasma-based films and methods for making and using the same

Publications (1)

Publication Number Publication Date
TR2021016542A2 true TR2021016542A2 (tr) 2022-01-21

Family

ID=59254013

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2021/016542A TR2021016542A2 (tr) 2016-05-31 2017-05-31 Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.

Country Status (12)

Country Link
US (2) US11383001B2 (tr)
EP (3) EP3701973B1 (tr)
CN (2) CN114796630A (tr)
AU (1) AU2017275577B2 (tr)
BR (2) BR112018074591B1 (tr)
CA (2) CA3224181A1 (tr)
DK (2) DK3463498T3 (tr)
ES (2) ES2936807T3 (tr)
IL (2) IL263093B (tr)
MX (2) MX2018014889A (tr)
TR (1) TR2021016542A2 (tr)
WO (1) WO2017210267A2 (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
US9526816B2 (en) 2010-12-08 2016-12-27 Convatec Technologies Inc. Wound exudate monitor accessory
WO2012078781A1 (en) 2010-12-08 2012-06-14 Convatec Technologies Inc. Integrated system for assessing wound exudates
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
KR20150099776A (ko) 2012-12-20 2015-09-01 컨바텍 테크놀러지스 인크 화학적 개질된 셀룰로스 섬유의 처리
KR20190008199A (ko) 2016-03-30 2019-01-23 시노보 게엠베하 상처에서 미생물 감염의 검출 방법
CN109310528B (zh) 2016-03-30 2021-07-20 康沃特克科技公司 检测伤口中的微生物感染
ES2882336T3 (es) 2016-07-08 2021-12-01 Convatec Technologies Inc Sistema flexible de presión negativa
WO2018009873A1 (en) 2016-07-08 2018-01-11 Convatec Technologies Inc. Fluid collection apparatus
EP3481360B1 (en) 2016-07-08 2022-03-09 ConvaTec Technologies Inc. Fluid flow sensing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
WO2022047367A1 (en) * 2020-08-31 2022-03-03 Vitruvian Medical Devices, Inc. Storage stable films comprising fibrin and/or fibrinogen
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof
WO2023170148A1 (en) * 2022-03-09 2023-09-14 Octapharma Ag Biodegradable, non-porous medical device and methods for making and using the same
WO2023170163A1 (en) 2022-03-09 2023-09-14 Octapharma Ag Mold for applying a liquid onto a plasma-based or cryoprecipitate-based film and method for coating a plasma-based or cryoprecipitate-based film

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918155T2 (de) 1988-05-02 1995-03-02 Project Hear Chirurgisches Klebstoffmaterial.
JPH05192387A (ja) 1990-11-08 1993-08-03 Matrix Pharmaceut Inc 生物医学的用途のための線維素／コラーゲン膜
EP0748215B1 (en) * 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
US20020131933A1 (en) 1996-01-16 2002-09-19 Yves Delmotte Biopolymer membrane and methods for its preparation
US20040147024A1 (en) * 2000-02-10 2004-07-29 Crowe John H. Therapeutic platelets and methods
ES2173812B1 (es) * 2001-03-01 2003-12-16 Ct Investig Energeticas Ciemat Dermis artificial y metodo de obtencion.
US20070048387A1 (en) * 2005-09-01 2007-03-01 Edwards Jeffrey D Tissue disruption treatment and composition for use thereof
US8529958B2 (en) 2006-10-17 2013-09-10 Carmell Therapeutics Corporation Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom
EP2381969B1 (en) * 2009-01-27 2016-05-18 REDDRESS Ltd. Methods for the preparation of wound dressings and a bank of wound dressings
WO2015188225A1 (en) * 2014-06-10 2015-12-17 M4 Medical Pty Ltd Wound dressing
US9848871B2 (en) * 2014-06-10 2017-12-26 Ethicon Llc Woven and fibrous materials for reinforcing a staple line

Also Published As

Publication number Publication date
MX2022001339A (es) 2022-03-11
RU2018146094A (ru) 2020-07-09
RU2018146094A3 (tr) 2020-09-25
AU2017275577B2 (en) 2021-04-29
CN109789245A (zh) 2019-05-21
US20200297893A1 (en) 2020-09-24
RU2021119683A (ru) 2021-07-12
US11383001B2 (en) 2022-07-12
IL263093A (en) 2018-12-31
IL284877A (en) 2021-08-31
IL263093B (en) 2021-08-31
RU2021119683A3 (tr) 2022-02-25
US20210008243A1 (en) 2021-01-14
AU2017275577A1 (en) 2018-12-06
BR112018074591A2 (pt) 2019-03-12
WO2017210267A2 (en) 2017-12-07
US11383002B2 (en) 2022-07-12
DK3701973T3 (da) 2023-01-09
EP3463498A2 (en) 2019-04-10
ES2900548T3 (es) 2022-03-17
WO2017210267A3 (en) 2018-02-15
EP4194017A1 (en) 2023-06-14
BR122022006547B1 (pt) 2022-12-13
EP3463498B1 (en) 2021-09-22
EP3701973A1 (en) 2020-09-02
ES2936807T3 (es) 2023-03-22
CA3224181A1 (en) 2017-12-07
CA3024511A1 (en) 2017-12-07
BR112018074591B1 (pt) 2022-07-12
CN109789245B (zh) 2022-10-18
CN114796630A (zh) 2022-07-29
EP3701973B1 (en) 2022-10-26
MX2018014889A (es) 2019-04-08
IL284877B (en) 2022-01-01
DK3463498T3 (da) 2021-12-20

Similar Documents

Publication Publication Date Title
TR2021016542A2 (tr) Plazma bazlı filmler ve bunları üretme ve kullanma usulleri.
CY1124131T1 (el) Συζευγματα αντι-ρτκ7 αντισωματος-φαρμακου
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
CL2019002824A1 (es) Anticuerpos anti-lag3.
CY1124663T1 (el) Αντιιικα παραγωγα ν4-υδροξυκυτιδινης
CL2017001393S1 (es) Automovil
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
CO2017004516A2 (es) Anticuerpos anti-ox40 humanizados
BR112017003414A2 (pt) composições compreendendo caseína e métodos para produzir as mesmas
CL2018002782A1 (es) Apósito modificado
PH12016501763A1 (en) Multispecific antibodies
CY1124215T1 (el) Μκ2 αναστολεις και χρησεις αυτων
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
BR112019012343A2 (pt) anticorpos il-11ra
CL2017001185S1 (es) Automovil
MA40579A (fr) Anticorps anti-cll-1 et immunoconjugués
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CL2019001554S1 (es) Automóvil.
CL2018000947S1 (es) Automóvil
CL2018001940S1 (es) Automóvil
EA201991997A1 (ru) Комбинированная терапия
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
MX2018009794A (es) Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.